{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:28:04Z","timestamp":1790807284447,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejradiology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Radiology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.ejrad.2017.03.015","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T22:19:33Z","timestamp":1490653173000},"page":"106-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Drug-eluting balloons for treatment of SFA and popliteal disease \u2013 A review of current status"],"prefix":"10.1016","volume":"91","author":[{"given":"Jos C.","family":"van den Berg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"March (1)","key":"10.1016\/j.ejrad.2017.03.015_bib0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.tvir.2009.10.008","article-title":"Drug eluting balloons","volume":"13","author":"Diehm","year":"2010","journal-title":"Tech. Vasc. Interv. Radiol."},{"issue":"June (3)","key":"10.1016\/j.ejrad.2017.03.015_bib0010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/CIRCINTERVENTIONS.109.903468","article-title":"Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial","volume":"3","author":"Laird","year":"2010","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"May (21)","key":"10.1016\/j.ejrad.2017.03.015_bib0015","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1161\/CIRCULATIONAHA.107.688341","article-title":"Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting","volume":"115","author":"Schillinger","year":"2007","journal-title":"Circulation"},{"issue":"April (2)","key":"10.1016\/j.ejrad.2017.03.015_bib0020","first-page":"248","article-title":"Management of in-stent restenosis in the superficial femoral artery","volume":"57","author":"van den Berg","year":"2016","journal-title":"J. Cardiovasc. Surg. (Torino)"},{"issue":"October (5)","key":"10.1016\/j.ejrad.2017.03.015_bib0025","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCINTERVENTIONS.111.962324","article-title":"Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results","volume":"4","author":"Dake","year":"2011","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"January (2)","key":"10.1016\/j.ejrad.2017.03.015_bib0030","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2004.11.026","article-title":"Prevalence and clinical impact of stent fractures after femoropopliteal stenting","volume":"45","author":"Scheinert","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"December (12)","key":"10.1016\/j.ejrad.2017.03.015_bib0035","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jvir.2009.08.019","article-title":"Paclitaxel-induced arterial wall toxicity and inflammation: Part 2 \u2013 Long-term tissue response in a minipig model","volume":"20","author":"Stampfl","year":"2009","journal-title":"J. Vasc. Interv. Radiol."},{"issue":"April (15)","key":"10.1016\/j.ejrad.2017.03.015_bib0040","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial","volume":"133","author":"Dake","year":"2016","journal-title":"Circulation"},{"issue":"June (23)","key":"10.1016\/j.ejrad.2017.03.015_bib0045","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1161\/CIRCULATIONAHA.108.839282","article-title":"Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis","volume":"119","author":"Unverdorben","year":"2009","journal-title":"Circulation"},{"issue":"February (1)","key":"10.1016\/j.ejrad.2017.03.015_bib0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ccl.2014.09.005","article-title":"Peripheral drug-eluting technology","volume":"33","author":"Franzone","year":"2015","journal-title":"Cardiol. Clin."},{"issue":"April (4)","key":"10.1016\/j.ejrad.2017.03.015_bib0055","first-page":"348","article-title":"Drug-coated balloons for restenosis prophylaxis","volume":"186","author":"Speck","year":"2014","journal-title":"Rofo"},{"issue":"February (1)","key":"10.1016\/j.ejrad.2017.03.015_bib0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1583\/08-2530.1","article-title":"Incidence, anatomical location, and clinical significance of compressions and fractures in infrapopliteal balloon-expandable metal stents","volume":"16","author":"Karnabatidis","year":"2009","journal-title":"J. Endovasc. Ther."},{"issue":"August (4)","key":"10.1016\/j.ejrad.2017.03.015_bib0065","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCINTERVENTIONS.109.873703","article-title":"Drug-eluting balloon: the comeback kid?","volume":"2","author":"Waksman","year":"2009","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"May (5)","key":"10.1016\/j.ejrad.2017.03.015_bib0070","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/hrt.2007.118059","article-title":"Prevention of restenosis: is angioplasty the answer?","volume":"93","author":"Scheller","year":"2007","journal-title":"Heart"},{"issue":"October (15)","key":"10.1016\/j.ejrad.2017.03.015_bib0075","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jacc.2014.06.1198","article-title":"Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial","volume":"64","author":"Zeller","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"June (24)","key":"10.1016\/j.ejrad.2017.03.015_bib0080","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/CIRCULATIONAHA.110.936922","article-title":"Drug-coated balloons for the prevention of vascular restenosis","volume":"121","author":"Gray","year":"2010","journal-title":"Circulation"},{"issue":"August (7)","key":"10.1016\/j.ejrad.2017.03.015_bib0085","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/01.CIR.0000138929.71660.E0","article-title":"Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis","volume":"110","author":"Scheller","year":"2004","journal-title":"Circulation"},{"issue":"December (6)","key":"10.1016\/j.ejrad.2017.03.015_bib0090","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/CIRCINTERVENTIONS.112.971630","article-title":"Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial","volume":"5","author":"Werk","year":"2012","journal-title":"Circ. Cardiovasc. Interv."},{"issue":"September (9)","key":"10.1016\/j.ejrad.2017.03.015_bib0095","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/01.rli.0000133815.22434.55","article-title":"The effects of paclitaxel on the three phases of restenosis: smooth muscle cell proliferation, migration, and matrix formation: an in vitro study","volume":"39","author":"Wiskirchen","year":"2004","journal-title":"Investig. Radiol."},{"issue":"July (2)","key":"10.1016\/j.ejrad.2017.03.015_bib0100","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/01.CIR.96.2.636","article-title":"Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery","volume":"96","author":"Axel","year":"1997","journal-title":"Circulation"},{"issue":"August (15)","key":"10.1016\/j.ejrad.2017.03.015_bib0105","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/S0195-668X(03)00317-8","article-title":"Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model","volume":"24","author":"Scheller","year":"2003","journal-title":"Eur. Heart J."},{"issue":"August (8)","key":"10.1016\/j.ejrad.2017.03.015_bib0110","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jcin.2014.05.008","article-title":"Drug delivering technology for endovascular management of infrainguinal peripheral artery disease","volume":"7","author":"Sarode","year":"2014","journal-title":"JACC Cardiovasc. Interv."},{"issue":"April (4)","key":"10.1016\/j.ejrad.2017.03.015_bib0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/clc.20066","article-title":"Systemic nanoparticle paclitaxel (nab-paclitaxel) for in-stent restenosis I (SNAPIST-I): a first-in-human safety and dose-finding study","volume":"30","author":"Margolis","year":"2007","journal-title":"Clin. Cardiol."},{"issue":"May (5)","key":"10.1016\/j.ejrad.2017.03.015_bib0120","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1055\/s-0029-1246028","article-title":"Plasma levels following application of paclitaxel-coated balloon catheters in patients with stenotic or occluded femoropopliteal arteries","volume":"183","author":"Freyhardt","year":"2011","journal-title":"Rofo"},{"issue":"April (4)","key":"10.1016\/j.ejrad.2017.03.015_bib0125","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/RLI.0b013e31820577df","article-title":"Dose response to Paclitaxel-coated balloon catheters in the porcine coronary overstretch and stent implantation model","volume":"46","author":"Kelsch","year":"2011","journal-title":"Investig. Radiol."},{"issue":"1","key":"10.1016\/j.ejrad.2017.03.015_bib0130","doi-asserted-by":"crossref","first-page":"e000117","DOI":"10.1136\/openhrt-2014-000117","article-title":"Mechanisms of tissue uptake and retention of paclitaxel-coated balloons: impact on neointimal proliferation and healing","volume":"1","author":"Granada","year":"2014","journal-title":"Open Heart"},{"issue":"July (8)","key":"10.1016\/j.ejrad.2017.03.015_bib0135","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jcin.2015.03.020","article-title":"Impact of paclitaxel dose on tissue pharmacokinetics and vascular healing: a comparative drug-coated balloon study in the familial hypercholesterolemic swine model of superficial femoral in-stent restenosis","volume":"8","author":"Gongora","year":"2015","journal-title":"JACC Cardiovasc. Interv."},{"issue":"May (5)","key":"10.1016\/j.ejrad.2017.03.015_bib0140","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00392-009-0008-2","article-title":"Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model","volume":"98","author":"Cremers","year":"2009","journal-title":"Clin. Res. Cardiol."},{"issue":"January (1)","key":"10.1016\/j.ejrad.2017.03.015_bib0145","first-page":"201","article-title":"Drug-eluting balloon: very short-term exposure and overlapping","volume":"101","author":"Cremers","year":"2009","journal-title":"Thromb. Haemost."},{"issue":"August (4)","key":"10.1016\/j.ejrad.2017.03.015_bib0150","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s00270-014-0904-3","article-title":"Calcium burden assessment and impact on drug-eluting balloons in peripheral arterial disease","volume":"37","author":"Fanelli","year":"2014","journal-title":"Cardiovasc. Interv. Radiol."},{"issue":"July (4)","key":"10.1016\/j.ejrad.2017.03.015_bib0155","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.carrev.2012.04.007","article-title":"Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: one-year single centre clinical results","volume":"13","author":"Cioppa","year":"2012","journal-title":"Cardiovasc. Revasc. Med."},{"issue":"December (6)","key":"10.1016\/j.ejrad.2017.03.015_bib0160","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1583\/13-4392R.1","article-title":"High-grade, non-flow-limiting dissections do not negatively impact long-term outcome after paclitaxel-coated balloon angioplasty: an additional analysis from the THUNDER study","volume":"20","author":"Tepe","year":"2013","journal-title":"J. Endovasc. Ther."},{"issue":"October (10)","key":"10.1016\/j.ejrad.2017.03.015_bib0165","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00392-008-0682-5","article-title":"Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter","volume":"97","author":"Scheller","year":"2008","journal-title":"Clin. Res. Cardiol."},{"issue":"February (7)","key":"10.1016\/j.ejrad.2017.03.015_bib0170","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa0706356","article-title":"Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg","volume":"358","author":"Tepe","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"January (1 Pt A)","key":"10.1016\/j.ejrad.2017.03.015_bib0175","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcin.2014.07.023","article-title":"Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial","volume":"8","author":"Tepe","year":"2015","journal-title":"JACC Cardiovasc. Interv."},{"issue":"September (13)","key":"10.1016\/j.ejrad.2017.03.015_bib0180","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1161\/CIRCULATIONAHA.107.735985","article-title":"Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial","volume":"118","author":"Werk","year":"2008","journal-title":"Circulation"},{"issue":"January (1)","key":"10.1016\/j.ejrad.2017.03.015_bib0185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","article-title":"The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty","volume":"7","author":"Scheinert","year":"2014","journal-title":"JACC Cardiovasc. Interv."},{"issue":"July (2)","key":"10.1016\/j.ejrad.2017.03.015_bib0190","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"June (3)","key":"10.1016\/j.ejrad.2017.03.015_bib0195","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/1526602816644592","article-title":"German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix drug-coated balloon in the treatment of femoropopliteal occlusive disease","volume":"23","author":"Scheinert","year":"2016","journal-title":"J. Endovasc. Ther."},{"issue":"February (5)","key":"10.1016\/j.ejrad.2017.03.015_bib0200","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCULATIONAHA.114.011004","article-title":"Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial","volume":"131","author":"Tepe","year":"2015","journal-title":"Circulation"},{"issue":"December (21)","key":"10.1016\/j.ejrad.2017.03.015_bib0205","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","article-title":"Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN.PACT SFA","volume":"66","author":"Laird","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"February (1)","key":"10.1016\/j.ejrad.2017.03.015_bib0210","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1526602814564383","article-title":"Paclitaxel-releasing balloon in femoropopliteal lesions using a BTHC excipient: twelve-month results from the BIOLUX P-I randomized trial","volume":"22","author":"Scheinert","year":"2015","journal-title":"J. Endovasc. Ther."},{"issue":"September (18)","key":"10.1016\/j.ejrad.2017.03.015_bib0215","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.jcin.2016.06.055","article-title":"Acotec drug-coated balloon catheter: randomized, multicenter, controlled clinical study in femoropopliteal arteries: evidence from the AcoArt I trial","volume":"9","author":"Jia","year":"2016","journal-title":"JACC Cardiovasc. Interv."},{"issue":"April (4)","key":"10.1016\/j.ejrad.2017.03.015_bib0220","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jvs.2014.01.041","article-title":"Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery","volume":"59","author":"Katsanos","year":"2014","journal-title":"J. Vasc. Surg."},{"issue":"April (2)","key":"10.1016\/j.ejrad.2017.03.015_bib0225","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/1526602815626557","article-title":"Systematic review and meta-analysis of randomized controlled trials of paclitaxel-coated balloon angioplasty in the femoropopliteal arteries: role of paclitaxel dose and bioavailability","volume":"23","author":"Katsanos","year":"2016","journal-title":"J. Endovasc. Ther."},{"issue":"April (4)","key":"10.1016\/j.ejrad.2017.03.015_bib0230","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jvir.2014.12.013","article-title":"Meta-analysis of drug-eluting balloon angioplasty and drug-eluting stent placement for infrainguinal peripheral arterial disease","volume":"26","author":"Baerlocher","year":"2015","journal-title":"J. Vasc. Interv. Radiol."},{"issue":"August (16)","key":"10.1016\/j.ejrad.2017.03.015_bib0235","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jcin.2016.06.008","article-title":"Drug-coated balloon versus plain balloon angioplasty for the treatment of femoropopliteal artery disease: an updated systematic review and meta-analysis of randomized clinical trials","volume":"9","author":"Giacoppo","year":"2016","journal-title":"JACC Cardiovasc. Interv."},{"issue":"August (8)","key":"10.1016\/j.ejrad.2017.03.015_bib0240","first-page":"CD011319","article-title":"Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs","author":"Kayssi","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"issue":"March (3)","key":"10.1016\/j.ejrad.2017.03.015_bib0245","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jcin.2013.01.128","article-title":"2-Year results of paclitaxel-eluting balloons for femoropopliteal artery disease: evidence from a multicenter registry","volume":"6","author":"Micari","year":"2013","journal-title":"JACC Cardiovasc. Interv."},{"issue":"August (2)","key":"10.1016\/j.ejrad.2017.03.015_bib0250","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ccd.25900","article-title":"Two-year results of a low-dose drug-coated balloon for revascularization of the femoropopliteal artery: outcomes from the ILLUMENATE first-in-human study","volume":"86","author":"Schroeder","year":"2015","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"April (7)","key":"10.1016\/j.ejrad.2017.03.015_bib0255","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jcin.2015.12.267","article-title":"Drug-coated balloons for complex femoropopliteal lesions: 2-year results of a real-world registry","volume":"9","author":"Schmidt","year":"2016","journal-title":"JACC Cardiovasc. Interv."},{"issue":"May (9)","key":"10.1016\/j.ejrad.2017.03.015_bib0260","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jcin.2016.02.014","article-title":"1-Year results of paclitaxel-coated balloons for long femoropopliteal artery disease: evidence from the SFA-Long study","volume":"9","author":"Micari","year":"2016","journal-title":"JACC Cardiovasc. Interv."},{"issue":"December (6)","key":"10.1016\/j.ejrad.2017.03.015_bib0265","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1583\/13-4416R.1","article-title":"Cost-effectiveness analysis of paclitaxel-coated balloons for endovascular therapy of femoropopliteal arterial obstructions","volume":"20","author":"Diehm","year":"2013","journal-title":"J. Endovasc. Ther."},{"issue":"October (4)","key":"10.1016\/j.ejrad.2017.03.015_bib0270","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ccd.25536","article-title":"Economic analysis of endovascular interventions for femoropopliteal arterial disease: a systematic review and budget impact model for the United States and Germany","volume":"84","author":"Pietzsch","year":"2014","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"August (9)","key":"10.1016\/j.ejrad.2017.03.015_bib0275","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/bjs.9195","article-title":"Cost-effectiveness analysis of enhancements to angioplasty for infrainguinal arterial disease","volume":"100","author":"Kearns","year":"2013","journal-title":"Br. J. Surg."},{"issue":"May (5)","key":"10.1016\/j.ejrad.2017.03.015_bib0280","doi-asserted-by":"crossref","first-page":"e011245","DOI":"10.1136\/bmjopen-2016-011245","article-title":"Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK","volume":"6","author":"Katsanos","year":"2016","journal-title":"BMJ Open"},{"issue":"November (22)","key":"10.1016\/j.ejrad.2017.03.015_bib0285","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.jcin.2016.08.036","article-title":"Cost-effectiveness of endovascular femoropopliteal intervention using drug-coated balloons versus standard percutaneous transluminal angioplasty: results from the IN.PACT SFA II trial","volume":"9","author":"Salisbury","year":"2016","journal-title":"JACC Cardiovasc. Interv."},{"issue":"May (6)","key":"10.1016\/j.ejrad.2017.03.015_bib0290","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/ccd.25179","article-title":"Safety and efficacy metrics for primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis and critical examination of current methodologies","volume":"83","author":"Vardi","year":"2014","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"May (18)","key":"10.1016\/j.ejrad.2017.03.015_bib0295","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa051303","article-title":"Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery","volume":"354","author":"Schillinger","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"July (3)","key":"10.1016\/j.ejrad.2017.03.015_bib0300","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/CIRCULATIONAHA.107.689141","article-title":"Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10cm in length: the femoral artery stenting trial (FAST)","volume":"116","author":"Krankenberg","year":"2007","journal-title":"Circulation"},{"issue":"September (3)","key":"10.1016\/j.ejrad.2017.03.015_bib0305","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jvs.2009.04.019","article-title":"Primary stenting of the superficial femoral and popliteal artery","volume":"50","author":"Dearing","year":"2009","journal-title":"J. Vasc. Surg."},{"issue":"June (3)","key":"10.1016\/j.ejrad.2017.03.015_bib0310","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1583\/13-4630MR.1","article-title":"Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions","volume":"21","author":"Zeller","year":"2014","journal-title":"J. Endovasc. Ther."},{"issue":"January (1)","key":"10.1016\/j.ejrad.2017.03.015_bib0315","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0002-8703(93)90057-G","article-title":"Progressive coronary dilation: an angioplasty technique that creates controlled arterial injury and reduces complications","volume":"125","author":"Banka","year":"1993","journal-title":"Am. Heart J."},{"issue":"April (4)","key":"10.1016\/j.ejrad.2017.03.015_bib0320","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1051-0443(07)61736-9","article-title":"Peripheral arterial balloon angioplasty: effect of short versus long balloon inflation times on the morphologic results","volume":"13","author":"Zorger","year":"2002","journal-title":"J. Vasc. Interv. Radiol."},{"issue":"April (4)","key":"10.1016\/j.ejrad.2017.03.015_bib0325","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1051-0443(07)61737-0","article-title":"Failure of prolonged dilation to improve long-term patency of femoropopliteal artery angioplasty: results of a prospective trial","volume":"13","author":"Soder","year":"2002","journal-title":"J. Vasc. Interv. Radiol."}],"container-title":["European Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X17301158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0720048X17301158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T05:53:48Z","timestamp":1535954028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0720048X17301158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":65,"alternative-id":["S0720048X17301158"],"URL":"https:\/\/doi.org\/10.1016\/j.ejrad.2017.03.015","relation":{},"ISSN":["0720-048X"],"issn-type":[{"value":"0720-048X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-eluting balloons for treatment of SFA and popliteal disease \u2013 A review of current status","name":"articletitle","label":"Article Title"},{"value":"European Journal of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejrad.2017.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}